We happily invest in companies anywhere in the world, but have a preference for standard jurisdictions and structures (e.g. Delaware C Corps, Hong Kong or Singapore Limited companies, SAFEs, etc.)
We don’t invest in markets we don’t understand well, or markets that require deep specialization to evaluate. For example, we generally don’t invest in healthcare and biotech startups.
While we do invest in crypto-currency and blockchain companies, we very rarely invest in crypto-tokens without an equity component.
We don’t invest via SPVs.
By mandate, we don’t invest in mainland China.
We don’t invest in uncapped notes and safes.